EE407 Budget Impact Analysis of the Use of Emicizumab in Prophylaxis for Severe Hemophilia A and Inhibitors in the Pediatric Population of the Dominican Republic
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.653
https://www.valueinhealthjournal.com/article/S1098-3015(22)02857-1/fulltext
Section Title :
Section Order :
10190
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02857-1&doi=10.1016/j.jval.2022.09.653